Salimbeni A - Search Results

1

Application of an integrated pyrolysis and chemical leaching process for pulper waste conversion into coal, hydrogen and chemical flocculating agent.

Salimbeni A, Di Bianca M, Maria Rizzo A, Chiaramonti D. Salimbeni A, et al. Waste Manag. 2024 Feb 15;174:549-557. doi: 10.1016/j.wasman.2023.12.038. Epub 2023 Dec 21. Waste Manag. 2024. PMID: 38134542

2

Mechanical Thrombectomy in Cervical Artery Dissection-Related Stroke.

Favruzzo F, De Rosa L, Salimbeni AF, Mozzetta S, Pieroni A, Viaro F, Cester G, Gabrieli JD, Causin F, Manara R, Baracchini C. Favruzzo F, et al. Among authors: salimbeni af. World Neurosurg. 2023 Jun 30:S1878-8750(23)00898-7. doi: 10.1016/j.wneu.2023.06.119. Online ahead of print. World Neurosurg. 2023. PMID: 37393999

3

11C-Radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]zofenoprilat.

Matarrese M, Salimbeni A, Turolla EA, Turozzi D, Moresco RM, Poma D, Magni F, Todde S, Rossetti C, Sciarrone MT, Bianchi G, Kienle MG, Fazio F. Matarrese M, et al. Among authors: salimbeni a. Bioorg Med Chem. 2004 Feb 1;12(3):603-11. doi: 10.1016/j.bmc.2003.10.054. Bioorg Med Chem. 2004. PMID: 14738971 Clinical Trial.

4

Synthesis and biological activity of the penem antibiotic MEN 10700 and its orally absorbed ester MEN 11505.

Arcamone FM, Altamura M, Perrotta E, Crea A, Manzini S, Poma D, Salimbeni A, Triolo A, Maggi CA. Arcamone FM, et al. Among authors: salimbeni a. J Antibiot (Tokyo). 2000 Oct;53(10):1086-95. doi: 10.7164/antibiotics.53.1086. J Antibiot (Tokyo). 2000. PMID: 11132952 Free article.

5

Design and synthesis of nonpeptide angiotensin II receptor antagonists featuring acyclic imidazole-mimicking structural units.

Angiolini M, Belvisi L, Poma D, Salimbeni A, Sciammetta N, Scolastico C. Angiolini M, et al. Among authors: salimbeni a. Bioorg Med Chem. 1998 Nov;6(11):2013-27. doi: 10.1016/s0968-0896(98)00160-6. Bioorg Med Chem. 1998. PMID: 9881093

6

A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists.

Belvisi L, Bravi G, Catalano G, Mabilia M, Salimbeni A, Scolastico C. Belvisi L, et al. Among authors: salimbeni a. J Comput Aided Mol Des. 1996 Dec;10(6):567-82. doi: 10.1007/BF00134180. J Comput Aided Mol Des. 1996. PMID: 9007690

7

Synthesis and renin inhibitory activity of novel angiotensinogen transition state analogues modified at the P(2)-histidine position.

Salimbeni A, Paleari F, Poma D, Criscuoli M, Scolastico C. Salimbeni A, et al. Eur J Med Chem. 1996;31(10):827-32. doi: 10.1016/0223-5234(96)83977-8. Eur J Med Chem. 1996. PMID: 22026939

8

N-3-substituted pyrimidinones as potent, orally active, AT1 selective angiotensin II receptor antagonists.

Salimbeni A, Canevotti R, Paleari F, Poma D, Caliari S, Fici F, Cirillo R, Renzetti AR, Subissi A, Belvisi L, et al. Salimbeni A, et al. J Med Chem. 1995 Nov 24;38(24):4806-20. doi: 10.1021/jm00024a008. J Med Chem. 1995. PMID: 7490730

9

Molecular pharmacology of LR-B/081, a new non-peptide angiotensin AT1 receptor antagonist.

Renzetti AR, Criscuoli M, Salimbeni A, Subissi A. Renzetti AR, et al. Among authors: salimbeni a. Eur J Pharmacol. 1995 Jul 18;290(2):151-6. doi: 10.1016/0922-4106(95)90028-4. Eur J Pharmacol. 1995. PMID: 8575530

10

Pharmacology of LR-B/057, a novel orally active AT1 receptor antagonist.

Renzetti AR, Cucchi P, Guelfi M, Cirillo R, Salimbeni A, Subissi A, Giachetti A. Renzetti AR, et al. Among authors: salimbeni a. J Cardiovasc Pharmacol. 1995 Mar;25(3):354-60. doi: 10.1097/00005344-199503000-00002. J Cardiovasc Pharmacol. 1995. PMID: 7769798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page